NM_003560.4:c.2098C>T

Variant summary

Our verdict is Pathogenic. The variant received 11 ACMG points: 11P and 0B. PVS1PM2PP5

The NM_003560.4(PLA2G6):​c.2098C>T​(p.Gln700*) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,461,350 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Variant results in nonsense mediated mRNA decay.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000014 ( 0 hom. )

Consequence

PLA2G6
NM_003560.4 stop_gained

Scores

5
1
1

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:5U:1

Conservation

PhyloP100: 7.61

Publications

1 publications found
Variant links:
Genes affected
PLA2G6 (HGNC:9039): (phospholipase A2 group VI) The protein encoded by this gene is an A2 phospholipase, a class of enzyme that catalyzes the release of fatty acids from phospholipids. The encoded protein may play a role in phospholipid remodelling, arachidonic acid release, leukotriene and prostaglandin synthesis, fas-mediated apoptosis, and transmembrane ion flux in glucose-stimulated B-cells. Several transcript variants encoding multiple isoforms have been described, but the full-length nature of only three of them have been determined to date. [provided by RefSeq, Dec 2010]
PLA2G6 Gene-Disease associations (from GenCC):
  • neurodegeneration with brain iron accumulation 2A
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Ambry Genetics, Genomics England PanelApp, Orphanet, Labcorp Genetics (formerly Invitae)
  • neurodegeneration with brain iron accumulation 2B
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • PLA2G6-associated neurodegeneration
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • autosomal recessive Parkinson disease 14
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 11 ACMG points.

PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 22-38113591-G-A is Pathogenic according to our data. Variant chr22-38113591-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 159758. Variant chr22-38113591-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 159758. Variant chr22-38113591-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 159758. Variant chr22-38113591-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 159758. Variant chr22-38113591-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 159758. Variant chr22-38113591-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 159758. Variant chr22-38113591-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 159758. Variant chr22-38113591-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 159758. Variant chr22-38113591-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 159758. Variant chr22-38113591-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 159758. Variant chr22-38113591-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 159758. Variant chr22-38113591-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 159758. Variant chr22-38113591-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 159758. Variant chr22-38113591-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 159758. Variant chr22-38113591-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 159758. Variant chr22-38113591-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 159758. Variant chr22-38113591-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 159758. Variant chr22-38113591-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 159758. Variant chr22-38113591-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 159758. Variant chr22-38113591-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 159758. Variant chr22-38113591-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 159758. Variant chr22-38113591-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 159758. Variant chr22-38113591-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 159758. Variant chr22-38113591-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 159758. Variant chr22-38113591-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 159758. Variant chr22-38113591-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 159758. Variant chr22-38113591-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 159758. Variant chr22-38113591-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 159758. Variant chr22-38113591-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 159758. Variant chr22-38113591-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 159758.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PLA2G6NM_003560.4 linkc.2098C>T p.Gln700* stop_gained Exon 15 of 17 ENST00000332509.8 NP_003551.2 O60733-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PLA2G6ENST00000332509.8 linkc.2098C>T p.Gln700* stop_gained Exon 15 of 17 1 NM_003560.4 ENSP00000333142.3 O60733-1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD2 exomes
AF:
0.00000398
AC:
1
AN:
251440
AF XY:
0.00000736
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000879
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000137
AC:
2
AN:
1461350
Hom.:
0
Cov.:
32
AF XY:
0.00000275
AC XY:
2
AN XY:
727004
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33474
American (AMR)
AF:
0.00
AC:
0
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26134
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39698
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86250
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53242
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.00000180
AC:
2
AN:
1111678
Other (OTH)
AF:
0.00
AC:
0
AN:
60384
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
Cov.:
32
Alfa
AF:
0.00
Hom.:
0
ExAC
AF:
0.00000824
AC:
1
EpiCase
AF:
0.00
EpiControl
AF:
0.0000593

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:5Uncertain:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Pathogenic:1Uncertain:1
Jul 01, 2022
CeGaT Center for Human Genetics Tuebingen
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

PLA2G6: PM2, PVS1:Moderate, PP4 -

Jul 09, 2019
Revvity Omics, Revvity
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Infantile neuroaxonal dystrophy Pathogenic:1
Jan 04, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change creates a premature translational stop signal (p.Gln700*) in the PLA2G6 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PLA2G6 are known to be pathogenic (PMID: 16783378, 18570303, 18799783, 22213678). This variant is present in population databases (rs587784346, gnomAD 0.0009%). This premature translational stop signal has been observed in individual(s) with PLA2G6-related conditions (PMID: 27848944). ClinVar contains an entry for this variant (Variation ID: 159758). For these reasons, this variant has been classified as Pathogenic. -

Iron accumulation in brain Pathogenic:1
Feb 08, 2013
Genetic Services Laboratory, University of Chicago
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

PLA2G6-associated neurodegeneration Pathogenic:1
Jan 24, 2023
Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:curation

The p.Gln700Ter variant in PLA2G6 has been reported in 2 individuals with PLA2G6-associated neurodegeneration (PMID: 27848944, 23100014) and has been identified in 0.0009% (1/113726) of European (non-Finnish) chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP ID: rs587784346). Although this variant has been seen in the general population in a heterozygous state, its frequency is low enough to be consistent with a recessive carrier frequency. This variant has also been reported in ClinVar (Variation ID#: 159758) and has been interpreted as pathogenic by Genetic Services Laboratory (University of Chicago) and PerkinElmer Genomics. Of the 2 affected individuals, both of them were homozygotes, which increases the likelihood that the p.Gln700Ter variant is pathogenic (PMID: 27848944, 23100014). This nonsense variant leads to a premature termination codon at position 700, which is predicted to lead to a truncated or absent protein. Loss of function of the PLA2G6 gene is an established disease mechanism in autosomal recessive PLA2G6-associated neurodegeneration. In summary, this variant meets criteria to be classified as pathogenic for autosomal recessive PLA2G6-associated neurodegeneration. ACMG/AMP Criteria applied: PVS1, PM3, PM2_supporting (Richards 2015). -

Infantile neuroaxonal dystrophy;C1857747:Neurodegeneration with brain iron accumulation 2B;C2751842:Autosomal recessive Parkinson disease 14 Pathogenic:1
Jan 28, 2024
Fulgent Genetics, Fulgent Genetics
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
0.63
D
BayesDel_noAF
Pathogenic
0.65
CADD
Pathogenic
47
DANN
Uncertain
1.0
Eigen
Pathogenic
1.0
Eigen_PC
Pathogenic
0.84
FATHMM_MKL
Pathogenic
0.99
D
PhyloP100
7.6
Vest4
0.97
GERP RS
4.4
Mutation Taster
=2/198
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.20
Details are displayed if max score is > 0.2
DS_DG_spliceai
0.20
Position offset: 49

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs587784346; hg19: chr22-38509598; API